SHMD Revolutionizes Stroke Diagnosis with AI-Powered Mobile Healthcare

SHMD (CEO Minyoung Song) Wins ‘K-Startup Award’ at the 11th Korea Industry Awards 2025 for Innovation in AI-Powered Mobile Healthcare Solutions

SHMD, a healthcare company founded by top-tier experts in healthcare, software development, and regulatory affairs, was honored with the ‘K-Startup Award’ at the 11th Korea Industry Awards 2025, hosted by Money Today. The award recognizes the company’s innovation in AI-based mobile healthcare technologies.

According to SHMD, the company focuses on the development of Cereband AI, a wearable self-diagnosis device for cerebral blood flow monitoring, and Braincheck AI, a self-assessment application for stroke risk. Notably, Braincheck AI utilizes cutting-edge AI algorithms to analyze carotid artery stenosis and detect signs of stroke in real time, offering a breakthrough solution for early diagnosis and prevention.

Following a successful round of angel investment and its recent certification as a venture company, SHMD is now setting its sights on entering the global stroke diagnostics market. The award is viewed as further validation of SHMD’s technological excellence and market potential.

Professor Junyoung Heo, co-founder of SHMD and a board-certified neurologist, stated,
“AI-based real-time cerebral blood flow monitoring technology represents a new paradigm in the early detection and preventive intervention of stroke.”
He added, “Given the critical importance of the golden hour in stroke treatment, Cereband AI and Braincheck AI can serve as transformative tools for continuous monitoring, significantly improving patient survival and prognosis. These technologies will open a new frontier in preventive stroke care by enabling daily health management for high-risk patients and rapid response by healthcare professionals.”